메뉴 건너뛰기




Volumn 18, Issue 8, 2011, Pages 598-608

Armed and targeted measles virus for chemovirotherapy of pancreatic cancer

Author keywords

measles virus; oncolysis; pancreatic cancer; prodrug converting enzyme; single chain antibody

Indexed keywords

FLUDARABINE; GEMCITABINE; ONCOLYTIC VIRUS; PROSTATE STEM CELL ANTIGEN; PURINE NUCLEOSIDE PHOSPHORYLASE;

EID: 79960557570     PISSN: 09291903     EISSN: 14765500     Source Type: Journal    
DOI: 10.1038/cgt.2011.30     Document Type: Article
Times cited : (50)

References (53)
  • 2
    • 77951755278 scopus 로고    scopus 로고
    • Pancreatic cancer
    • Hidalgo M. Pancreatic cancer. N Engl J Med 2010; 362: 1605-1617.
    • (2010) N Engl J Med , vol.362 , pp. 1605-1617
    • Hidalgo, M.1
  • 5
    • 34547218986 scopus 로고    scopus 로고
    • Oncolytic viruses in cancer therapy
    • DOI 10.1016/j.canlet.2007.02.002, PII S0304383507000468
    • Vaha-Koskela MJ, Heikkila JE, Hinkkanen AE. Oncolytic viruses in cancer therapy. Cancer Lett 2007; 254: 178-216. (Pubitemid 47126688)
    • (2007) Cancer Letters , vol.254 , Issue.2 , pp. 178-216
    • Vaha-Koskela, M.J.V.1    Heikkila, J.E.2    Hinkkanen, A.E.3
  • 9
    • 50549096499 scopus 로고    scopus 로고
    • Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity
    • Allen C, Paraskevakou G, Iankov I, Giannini C, Schroeder M, Sarkaria J et al. Interleukin-13 displaying retargeted oncolytic measles virus strains have significant activity against gliomas with improved specificity. Mol Ther 2008; 16: 1556-1564.
    • (2008) Mol Ther , vol.16 , pp. 1556-1564
    • Allen, C.1    Paraskevakou, G.2    Iankov, I.3    Giannini, C.4    Schroeder, M.5    Sarkaria, J.6
  • 10
    • 67449152194 scopus 로고    scopus 로고
    • Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer
    • Liu C, Hasegawa K, Russell SJ, Sadelain M, Peng KW. Prostate-specific membrane antigen retargeted measles virotherapy for the treatment of prostate cancer. Prostate 2009; 69: 1128-1141.
    • (2009) Prostate , vol.69 , pp. 1128-1141
    • Liu, C.1    Hasegawa, K.2    Russell, S.J.3    Sadelain, M.4    Peng, K.W.5
  • 12
    • 77954814628 scopus 로고    scopus 로고
    • Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy
    • Li H, Peng KW, Dingli D, Kratzke RA, Russell SJ. Oncolytic measles viruses encoding interferon beta and the thyroidal sodium iodide symporter gene for mesothelioma virotherapy. Cancer Gene Ther 2010; 17: 550-558.
    • (2010) Cancer Gene Ther , vol.17 , pp. 550-558
    • Li, H.1    Peng, K.W.2    Dingli, D.3    Kratzke, R.A.4    Russell, S.J.5
  • 13
    • 78649985500 scopus 로고    scopus 로고
    • Mantle cell lymphoma salvage regimen: Synergy between a reprogrammed oncolytic virus and two chemotherapeutics
    • Ungerechts G, Frenzke ME, Yaiw KC, Miest T, Johnston PB, Cattaneo R. Mantle cell lymphoma salvage regimen: synergy between a reprogrammed oncolytic virus and two chemotherapeutics. Gene Therapy 2010; 17: 1506-1516.
    • (2010) Gene Therapy , vol.17 , pp. 1506-1516
    • Ungerechts, G.1    Frenzke, M.E.2    Yaiw, K.C.3    Miest, T.4    Johnston, P.B.5    Cattaneo, R.6
  • 14
    • 0027426010 scopus 로고
    • The human CD46 molecule is a receptor for measles virus (Edmonston strain)
    • DOI 10.1016/0092-8674(93)80071-L
    • Dorig RE, Marcil A, Chopra A, Richardson CD. The human CD46 molecule is a receptor for measles virus (Edmonston strain). Cell 1993; 75: 295-305. (Pubitemid 23320293)
    • (1993) Cell , vol.75 , Issue.2 , pp. 295-305
    • Dorig, R.E.1    Marcil, A.2    Chopra, A.3    Richardson, C.D.4
  • 16
    • 0034710650 scopus 로고    scopus 로고
    • Slam (CDw150) is a cellular receptor for measles virus
    • DOI 10.1038/35022579
    • Tatsuo H, Ono N, Tanaka K, Yanagi Y. SLAM (CDw150) is a cellular receptor for measles virus. Nature 2000; 406: 893-897. (Pubitemid 30664265)
    • (2000) Nature , vol.406 , Issue.6798 , pp. 893-897
    • Tatsuo, H.1    Ono, N.2    Tanaka, K.3    Yanagi, Y.4
  • 17
    • 0345734198 scopus 로고    scopus 로고
    • Selectively Receptor-Blind Measles Viruses: Identification of Residues Necessary for SLAM- or CD46-Induced Fusion and Their Localization on A New Hemagglutinin Structural Model
    • DOI 10.1128/JVI.78.1.302-313.2004
    • Vongpunsawad S, Oezgun N, Braun W, Cattaneo R. Selectively receptor-blind measles viruses: identification of residues necessary for SLAM-or CD46-induced fusion and their localization on a new hemagglutinin structural model. J Virol 2004; 78: 302-313. (Pubitemid 37549743)
    • (2004) Journal of Virology , vol.78 , Issue.1 , pp. 302-313
    • Vongpunsawad, S.1    Oezgun, N.2    Braun, W.3    Cattaneo, R.4
  • 21
    • 0037612079 scopus 로고    scopus 로고
    • Immunocytochemical analysis of prostate stem cell antigen as an adjunct marker for the detection of urothelial transitional cell carcinoma in voided urine specimens
    • DOI 10.1097/01.ju.0000064929.43602.17
    • Cheng L, Reiter RE, Jin Y, Sharon H, Wieder J, Lane TF et al. Immunocytochemical analysis of prostate stem cell antigen as adjunct marker for detection of urothelial transitional cell carcinoma in voided urine specimens. J Urol 2003; 169: 2094-2100. (Pubitemid 36576725)
    • (2003) Journal of Urology , vol.169 , Issue.6 , pp. 2094-2100
    • Cheng, L.1    Reiter, R.E.2    Jin, Y.3    Sharon, H.4    Wieder, J.5    Lane, T.F.6    Rao, J.7
  • 24
    • 0036903141 scopus 로고    scopus 로고
    • Armed therapeutic viruses: Strategies and challenges to arming oncolytic viruses with therapeutic genes
    • DOI 10.1038/sj.cgt.7700542
    • Hermiston TW, Kuhn I. Armed therapeutic viruses: strategies and challenges to arming oncolytic viruses with therapeutic genes. Cancer Gene Ther 2002; 9: 1022-1035. (Pubitemid 35462564)
    • (2002) Cancer Gene Therapy , vol.9 , Issue.12 , pp. 1022-1035
    • Hermiston, T.W.1    Kuhn, I.2
  • 26
    • 34250839415 scopus 로고    scopus 로고
    • Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells
    • DOI 10.1002/pros.20608
    • Morgenroth A, Cartellieri M, Schmitz M, Gunes S, Weigle B, BachmannMet al. Targeting of tumor cells expressing the prostate stem cell antigen (PSCA) using genetically engineered T-cells. Prostate 2007; 67: 1121-1131. (Pubitemid 46983341)
    • (2007) Prostate , vol.67 , Issue.10 , pp. 1121-1131
    • Morgenroth, A.1    Cartellieri, M.2    Schmitz, M.3    Gunes, S.4    Weigle, B.5    Bachmann, M.6    Abken, H.7    Rieber, E.P.8    Temme, A.9
  • 27
    • 70350690548 scopus 로고    scopus 로고
    • High-throughput detection and multiplex identification of cell contaminations
    • Schmitt M, Pawlita M. High-throughput detection and multiplex identification of cell contaminations. Nucleic Acids Res 2009; 37: e119.
    • (2009) Nucleic Acids Res , vol.37
    • Schmitt, M.1    Pawlita, M.2
  • 28
    • 0032829772 scopus 로고    scopus 로고
    • Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent protein-expressing recombinant virus
    • Duprex WP, McQuaid S, Hangartner L, Billeter MA, Rima BK. Observation of measles virus cell-to-cell spread in astrocytoma cells by using a green fluorescent proteinexpressing recombinant virus. J Virol 1999; 73: 9568-9575. (Pubitemid 29487112)
    • (1999) Journal of Virology , vol.73 , Issue.11 , pp. 9568-9575
    • Duprex, W.P.1    McQuaid, S.2    Hangartner, L.3    Billeter, M.A.4    Rima, B.K.5
  • 30
    • 0027291943 scopus 로고
    • The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA
    • Calain P, Roux L. The rule of six, a basic feature for efficient replication of Sendai virus defective interfering RNA. J Virol 1993; 67: 4822-4830. (Pubitemid 23215963)
    • (1993) Journal of Virology , vol.67 , Issue.8 , pp. 4822-4830
    • Calain, P.1    Roux, L.2
  • 31
    • 59449089665 scopus 로고    scopus 로고
    • Improvement of gemcitabine-based therapy of pancreatic carcinoma by means of oncolytic parvovirus H-1PV
    • Angelova AL, Aprahamian M, Grekova SP, Hajri A, Leuchs B, Giese NA et al. Improvement of gemcitabine-based therapy of pancreatic carcinoma by means of oncolytic parvovirus H-1PV. Clin Cancer Res 2009; 15: 511-519.
    • (2009) Clin Cancer Res , vol.15 , pp. 511-519
    • Angelova, A.L.1    Aprahamian, M.2    Grekova, S.P.3    Hajri, A.4    Leuchs, B.5    Giese, N.A.6
  • 32
    • 3142745262 scopus 로고    scopus 로고
    • High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus
    • DOI 10.1158/0008-5472.CAN-04-0884
    • Anderson BD, Nakamura T, Russell SJ, Peng KW. High CD46 receptor density determines preferential killing of tumor cells by oncolytic measles virus. Cancer Res 2004; 64: 4919-4926. (Pubitemid 38924538)
    • (2004) Cancer Research , vol.64 , Issue.14 , pp. 4919-4926
    • Anderson, B.D.1    Nakamura, T.2    Russell, S.J.3    Peng, K.-W.4
  • 38
    • 0032188825 scopus 로고    scopus 로고
    • Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines
    • Mackey JR, Mani RS, Selner M, Mowles D, Young JD, Belt JA et al. Functional nucleoside transporters are required for gemcitabine influx and manifestation of toxicity in cancer cell lines. Cancer Res 1998; 58: 4349-4357. (Pubitemid 28450036)
    • (1998) Cancer Research , vol.58 , Issue.19 , pp. 4349-4357
    • Mackey, J.R.1    Mani, R.S.2    Selner, M.3    Mowles, D.4    Young, J.D.5    Belt, J.A.6    Crawford, C.R.7    Cass, C.E.8
  • 42
    • 19944431439 scopus 로고    scopus 로고
    • Effective gene therapy of biliary tract cancers by a conditionally replicative adenovirus expressing uracil phosphoribosyltransferase: Significance of timing of 5-fluorouracil administration
    • Seo E, Abei M, Wakayama M, Fukuda K, Ugai H, Murata T et al. Effective gene therapy of biliary tract cancers by a conditionally replicative adenovirus expressing uracil phosphoribosyltransferase: significance of timing of 5-fluorouracil administration. Cancer Res 2005; 65: 546-552.
    • (2005) Cancer Res , vol.65 , pp. 546-552
    • Seo, E.1    Abei, M.2    Wakayama, M.3    Fukuda, K.4    Ugai, H.5    Murata, T.6
  • 44
    • 67449146907 scopus 로고    scopus 로고
    • Development of gene therapy in association with clinically used cytotoxic deoxynucleoside analogues
    • Hebrard C, Dumontet C, Jordheim LP. Development of gene therapy in association with clinically used cytotoxic deoxynucleoside analogues. Cancer Gene Ther 2009; 16: 541-550.
    • (2009) Cancer Gene Ther , vol.16 , pp. 541-550
    • Hebrard, C.1    Dumontet, C.2    Jordheim, L.P.3
  • 45
    • 0033999780 scopus 로고    scopus 로고
    • Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene
    • Mohr L, Shankara S, Yoon SK, Krohne TU, Geissler M, Roberts B et al. Gene therapy of hepatocellular carcinoma in vitro and in vivo in nude mice by adenoviral transfer of the Escherichia coli purine nucleoside phosphorylase gene. Hepatology 2000; 31: 606-614. (Pubitemid 30118628)
    • (2000) Hepatology , vol.31 , Issue.3 , pp. 606-614
    • Mohr, L.1    Shankara, S.2    Yoon, S.-K.3    Krohne, T.U.4    Geissler, M.5    Roberts, B.6    Blum, H.E.7    Wands, J.R.8
  • 46
    • 42649141632 scopus 로고    scopus 로고
    • Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter
    • Cai X, Zhou J, Chang Y, Sun X, Li P, Lin J. Targeting gene therapy for hepatocarcinoma cells with the E. coli purine nucleoside phosphorylase suicide gene system directed by a chimeric alpha-fetoprotein promoter. Cancer Lett 2008; 264: 71-82.
    • (2008) Cancer Lett , vol.264 , pp. 71-82
    • Cai, X.1    Zhou, J.2    Chang, Y.3    Sun, X.4    Li, P.5    Lin, J.6
  • 48
    • 14244249270 scopus 로고    scopus 로고
    • Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudo-metastases in a mouse model of prostate cancer
    • DOI 10.1002/jgm.629
    • Martiniello-Wilks R, Wang XY, Voeks DJ, Dane A, Shaw JM, Mortensen E et al. Purine nucleoside phosphorylase and fludarabine phosphate gene-directed enzyme prodrug therapy suppresses primary tumour growth and pseudometastases in a mouse model of prostate cancer. J Gene Med 2004; 6: 1343-1357. (Pubitemid 40287706)
    • (2004) Journal of Gene Medicine , vol.6 , Issue.12 , pp. 1343-1357
    • Martiniello-Wilks, R.1    Wang, X.Y.2    Voeks, D.J.3    Dane, A.4    Shaw, J.M.5    Mortensen, E.6    Both, G.W.7    Russell, P.J.8
  • 49
    • 33847043563 scopus 로고    scopus 로고
    • Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts
    • Kikuchi E, Menendez S, Ozu C, Ohori M, Cordon-Cardo C, Logg CR et al. Delivery of replication-competent retrovirus expressing Escherichia coli purine nucleoside phosphorylase increases the metabolism of the prodrug, fludarabine phosphate and suppresses the growth of bladder tumor xenografts. Cancer Gene Ther 2007; 14: 279-286.
    • (2007) Cancer Gene Ther , vol.14 , pp. 279-286
    • Kikuchi, E.1    Menendez, S.2    Ozu, C.3    Ohori, M.4    Cordon-Cardo, C.5    Logg, C.R.6
  • 51
    • 0030710957 scopus 로고    scopus 로고
    • Relative efficiency of tumor cell killing in vitro by two enzyme- prodrug systems delivered by identical adenovirus vectors
    • Lockett LJ, Molloy PL, Russell PJ, Both GW. Relative efficiency of tumor cell killing in vitro by two enzyme-prodrug systems delivered by identical adenovirus vectors. Clin Cancer Res 1997; 3: 2075-2080. (Pubitemid 27505135)
    • (1997) Clinical Cancer Research , vol.3 , Issue.11 , pp. 2075-2080
    • Lockett, L.J.1    Molloy, P.L.2    Russell, P.J.3    Both, G.W.4
  • 52
    • 0029094708 scopus 로고
    • Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene
    • Hughes BW, Wells AH, Bebok Z, Gadi VK, Garver Jr RI, Parker WB et al. Bystander killing of melanoma cells using the human tyrosinase promoter to express the Escherichia coli purine nucleoside phosphorylase gene. Cancer Res 1995; 55: 3339-3345.
    • (1995) Cancer Res , vol.55 , pp. 3339-3345
    • Hughes, B.W.1    Wells, A.H.2    Bebok, Z.3    Gadi, V.K.4    Garver Jr., R.I.5    Parker, W.B.6
  • 53
    • 4143111313 scopus 로고    scopus 로고
    • Characterization of a gemcitabine-resistant murine leukemic cell line: Reversion of in vitro resistance by a mononucleotide prodrug
    • DOI 10.1158/1078-0432.CCR-04-0506
    • Jordheim LP, Cros E, Gouy MH, Galmarini CM, Peyrottes S, Mackey J et al. Characterization of a gemcitabineresistant murine leukemic cell line: reversion of in vitro resistance by a mononucleotide prodrug. Clin Cancer Res 2004; 10: 5614-5621. (Pubitemid 39100503)
    • (2004) Clinical Cancer Research , vol.10 , Issue.16 , pp. 5614-5621
    • Jordheim, L.P.1    Cros, E.2    Gouy, M.-H.3    Galmarini, C.M.4    Peyrottes, S.5    Mackey, J.6    Perigaud, C.7    Dumontet, C.8


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.